1. Home
  2. BGLC

as of 12-12-2025 10:58am EST

$4.17
$0.09
-2.11%
Stocks Health Care Medical Specialities Nasdaq

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

Chart Type:
Time Range:
Founded: 2017 Country:
Malaysia
Malaysia
Employees: N/A City: KUALA LUMPUR
Market Cap: 10.1M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 201.4K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.28 EPS Growth: N/A
52 Week Low/High: $2.01 - $15.60 Next Earning Date: 11-14-2025
Revenue: $9,465,006 Revenue Growth: 2.21%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AI-Powered BGLC Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 84.03%
84.03%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: